News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Ciara Freeman: How soluble BCMA quantification and MTV from SOC PET can predict tumor burden
Ciara Freeman/X
Dec 15, 2024, 10:14

Ciara Freeman: How soluble BCMA quantification and MTV from SOC PET can predict tumor burden

Ciara Freeman, Assistant Member, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, shared on X:

“Excited to share our latest work in Blood Journal.

We demonstrate how soluble BCMA (sBCMA) quantification and MTV from SOC PET can predict tumor burden, response, and toxicity from CAR-T!

True multidisciplinary effort!”

Tumor burden quantified by Soluble B-Cell Maturation Antigen and Metabolic Tumor Volume determine myeloma CAR-T outcomes

Authors: Ciara L Freeman, Jerald Noble, Meghan Menges, Ricardo Villanueva, Justyn Y Nakashima, Nicholas B Figura, R. Petter Tonseth, Dietrich Werner Idiaquez, Lawrence Skelson, Eric C Smith, Julieta Abraham-Miranda, Salvatore Corallo, Gabriel De Avila, Omar Castaneda Puglianini, Hien D Liu, Melissa Alsina, Taiga Nishihori, Kenneth H Shain, Rachid C Baz, Brandon J Blue, Ariel Grajales-Cruz, John M. Koomen, Reginald M Atkins, Doris K Hansen, Ariosto Siqueira Silva, Jongphil Kim, Yoganand Balagurunathan, and Frederick L Locke.

Ciara Freeman

Ariel Grajales-Cruz Ariosto Siqueira Silva BCMA Blood Journal Brandon J Blue cancer Ciara Freeman Ciara L. Freeman Dietrich Werner Idiaquez Doris K. Hansen Eric C Smith Frederick L. Locke Gabriel De Avila Hien D Liu Jerald Noble John M. Koomen Jongphil Kim Julieta Abraham-Miranda Justyn Y Nakashima Kenneth H Shain Lawrence Skelson Meghan Menges Melissa Alsina Nicholas B Figura Omar Castaneda Puglianini OncoDaily Oncology R. Petter Tonseth Rachid C Baz Reginald M Atkins Ricardo Villanueva Salvatore Corallo Taiga Nishihori tumor burden Yoganand Balagurunathan
Special Coverage
Blog
May 9, 2025, 10:15
Sarah Sammons Comments on TDXd Use in Early HER2+ Breast Cancer
Blog
May 9, 2025, 10:04
Aakash Desai: AI in Predicting EGFR Mutations from Whole Slide Images in Lung Cancer
Blog
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic
Science
May 9, 2025, 08:02
Ashish Kamat: Predictive Value of AI Histologic Biomarker CHAI in NMIBC Treatment
Drugs
May 9, 2025, 07:54
Rahul Banerjee: Financial Toxicity Is the First Side Effect of Lenalidomide in Multiple Myeloma
Blog
May 9, 2025, 07:41
Eric Singhi: First-Year Fellow’s Graduation from the Singhi Clinic